Legal
Medical Consent
Effective Date: November 18, 2026
Last Updated: November 18, 2026
This page explains the consents relevant to using SurpassMD, a brand operated by Gangotri46 Ventures LLC. Clinical care is provided by Wasef Health and the applicable affiliated professional entity and treating Provider. The applicable consent is presented for affirmative acceptance before the activity it covers. Reading this public page alone is not a signature or a record of clinical consent.
The treating Medical Group’s own clinical consent and any applicable state-specific forms govern the clinical care relationship. This SurpassMD explanation does not replace those documents. A separate Notice of Privacy Practices describes medical-record rights and is not a treatment-consent form.
Telehealth is not emergency care. Call 911 or seek immediate in-person care for an emergency.
Clinical consent, payment authorization, acknowledgments of notice receipt, and optional marketing choices serve different purposes. They are presented distinctly where required. Refusing optional marketing does not affect access to care.
1. Consent to Telehealth
Care may be delivered asynchronously through submitted questionnaires and secure messages or through audio, video, or an in-person referral when clinically required. The Medical Group presents the clinical and state-specific forms applicable to your care for affirmative acceptance. Review the Medical Group’s privacy notice separately; it explains medical-information practices and is not a clinical-consent form.
Clinical services are provided by Wasef Health, PC and, where applicable, its affiliated professional entities (the “Medical Group”) and their independently licensed clinicians (the “Providers”). The professional entity and clinician responsible for your care are identified to you in the patient-care process. SurpassMD provides technology access and non-clinical administrative, billing, and support services; it does not practice medicine or direct clinical judgment.
I consent to evaluation and, where appropriate, treatment by the Medical Group through telehealth. This may involve questionnaires, secure messages, audio, video, or other permitted electronic communications. I understand the potential benefits of access and convenience and the risks of incomplete information, technology failure, delay, unauthorized disclosure, and the absence of an in-person examination. My Provider may request additional information or recommend in-person care.
I will give truthful and complete information about my identity, current physical location, health history, medications, allergies, and symptoms. I may ask questions and may withdraw consent to future telehealth care by notifying my Provider through my patient account. Withdrawal does not reverse care already provided or required recordkeeping. Telehealth messages are not continuously monitored for emergencies; for an emergency, call 911 or seek immediate in-person care.
I understand that care and medication availability depend on my physical location at the time of service and the provider’s and pharmacy’s authorizations. Services are not available outside the United States, in U.S. territories, or at APO/FPO addresses. I will tell my Provider if my location changes.
The treating Medical Group may present additional clinical or state-specific consents. I will review those documents before accepting them. SurpassMD’s website terms do not replace those clinical consents or the Provider’s independent judgment.
Asynchronous care means that information may be submitted and reviewed at different times rather than during a live appointment. My Provider may use my health questionnaire and secure messages and may require an audio, video, or in-person evaluation when appropriate. I understand that no diagnosis, treatment, or prescription is guaranteed.
I may ask questions before giving consent. I may request access to my clinical records or ask to withdraw future clinical consent through my care team or contact@wasef-health.com. Withdrawal does not reverse care already provided or override a legal obligation to retain clinical records. A request to close a patient account is distinct from destruction of the medical record.
2. Notice of Privacy Practices and Medical Records
The Medical Group’s Notice of Privacy Practices explains the medical-information practices and request process. If a different treating professional entity’s notice applies, it will be provided to me. My dispensing Pharmacy provides its own notice. I may request a copy. Any acknowledgment of receipt is separate from treatment consent and from authorizations requiring specific permission. Nothing here deems me to have received a notice that was not actually provided.
3. Financial Agreement and Authorization to Charge
I understand that SurpassMD operates a cash-pay program. Before I authorize payment, I will be shown the total price, billing interval, any prepaid term, and what is included. I authorize the disclosed payment arrangement, including a possible temporary card authorization hold at checkout and collection for the initial treatment purchase only after a Provider issues the prescription. If an initial prescription is not issued, I pay nothing: the hold is released, or any collected payment is refunded in full without consultation, administrative, or cancellation fee deductions. My financial institution controls when a pending hold disappears. A monthly equivalent for a prepaid multi-month plan does not mean I will be billed monthly; billing and shipping frequency may differ, including three-month medication shipments where disclosed.
If I affirmatively enroll in a subscription, I authorize the recurring amount and interval disclosed at checkout until I turn off automatic renewal. I may cancel future renewals anytime through my patient portal. If I need support, I may contact patient care at care@surpassmd.com. A cancellation request received before the next renewal payment is processed stops that renewal and later renewals. Turning off renewal preserves my current paid term and scheduled shipments, subject to continued clinical eligibility, and does not itself create a refund right.
I understand that I may voluntarily cancel the current purchase before a Provider issues the prescription and receive release of any authorization hold or a full refund of any payment collected. Once the prescription is issued, voluntary cancellation, a change of mind or non-use does not entitle me to a refund, including for unused medication, unshipped medication or remaining months of a prepaid package. If a Provider confirms that I can no longer continue for medical reasons, or SurpassMD or its service partners cannot fulfill the purchased treatment, I will receive a refund for the affected future treatment not yet dispensed or shipped. The refund uses the original prepaid price allocation, or a proportional allocation by months if no separate allocation was disclosed, without repricing fulfilled months or deducting a cancellation fee. Medication-problem remedies, billing-error corrections, and nonwaivable rights remain available under the Cancellation and Refund Policy. I have not been promised a prescription or a particular result. The payment statement descriptor is disclosed at checkout.
4. Consent to the Use of Compounded Medications
I understand that a product prescribed to me may be a compounded medication, that compounded medications are not approved by the U.S. Food and Drug Administration (FDA), and that the FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. I understand that a compounded medication may differ in appearance, packaging, or other characteristics from any FDA-approved product, and that I have reviewed the Important Safety Information made available to me. I understand that the specific pharmacy, formulation, concentration, inactive ingredients, storage requirements, dosing device, and the patient-specific reason for compounding are determined by my Provider and the Pharmacy and are disclosed to me in the information provided with my medication, which I agree to review. For injectable medications such as GLP-1 medications, I understand that concentrations may vary, that a dose may be expressed in milligrams or in units, and that measuring or self-administering the wrong amount, making titration errors, or failing to store the medication at the correct temperature can be dangerous; I will follow the instructions provided and ask my Provider if I am unsure. I consent to treatment with a compounded medication if my Provider determines it is appropriate.
5. Pharmacy Fulfillment and Shipping Authorization
I authorize the transmission of my prescription and the information needed to a licensed dispensing pharmacy for requested treatment, as permitted by law and applicable consent. I understand that SurpassMD uses more than one pharmacy partner and that the pharmacy may depend on my location, treatment, licensure, and availability. I may ask for the pharmacy’s identity and contact details before dispensing.
I authorize shipment to the address I provide, will keep that address accurate, and will follow storage and handling instructions. I will inspect medication immediately upon receipt, will not use medication that appears incorrect, damaged, leaking or affected by improper temperature, and will contact the Pharmacy and care@surpassmd.com immediately. I will retain the packaging and available photographs. No fixed numerical reporting deadline applies. Replacement is the primary remedy for verified medication problems. If an appropriate replacement or reshipment cannot be provided, the original amount attributable to the verified affected medication will be refunded even if it was already dispensed or shipped, under the Cancellation and Refund Policy and applicable law. Any prescription transfer or substitution requires professional review and any notice or consent required by law.
6. Electronic Communications and Optional Marketing
I agree to receive program notices, agreements, billing information, and care communications electronically, subject to applicable law. I will use my patient account for clinical questions and understand that ordinary email or text may be less secure than the account’s messaging service. I will tell my care team if I need an alternative communication method.
Marketing consent is optional, is presented separately where required, and is not a condition of purchase or care. I may unsubscribe from marketing email or reply STOP to marketing texts. Message and data rates may apply. An opt-out of marketing does not cancel my subscription.
7. Voluntary Consent
I confirm that I am at least 18 years old, that the information I provide is truthful and complete, that I have had the opportunity to ask questions, and that I give the applicable consents voluntarily. I may decline or withdraw consent to future clinical care by notifying my Provider, although the Provider may then be unable to deliver the affected service. This does not mean I must accept optional marketing. Refusing or withdrawing marketing consent does not affect access to care, and declining to sign an acknowledgment of notice receipt is not itself refusal of treatment consent or authorization for special uses of my medical information.
8. Questions
To turn off automatic renewal, use your patient portal. If you have questions about these consents or need support with a shipment, safety concern, cancellation or refund, contact patient care at care@surpassmd.com, or by mail at Gangotri46 Ventures LLC dba SurpassMD, 30 N Gould St, Ste R, Sheridan, WY 82801-6317.
© 2026 Gangotri46 Ventures LLC dba SurpassMD. All rights reserved.